Early Dementia: Impairments of Working Memory and Inhibitory Control
Distinguishing between impairments of working memory and inhibitory control in cases of early dementia.
MAC Clinical Research is a full-service, global, pharmaceutical contract research organization (CRO), with science at the heart of everything we do. Read More…
Effective solutions to successfully deliver your clinical trials.


MAC conduct clinical trials for most of the worlds leading pharma and biotechs. Read More…
We offer an array of scientific solutions to support any clinical trial. Read More…
MAC’s flexible strategic consulting can support your project at any stage. Read More…




Distinguishing between impairments of working memory and inhibitory control in cases of early dementia.
The disengagement of visual attention in Alzheimer’s disease: a longitudinal eye-tracking study.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Reducing Human Error in Checking Concomitant Medications.
The Use of Decision Support Systems to Improve Patient Safety and the Quality of Patient Care in Clinical Trials.
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis.
Inhibitory Control of Saccadic Eye Movements and Cognitive Impairment in Alzheimer’s Disease.